Article révisé par les pairs
Titre:
  • Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel
Auteur:Durbecq, Virginie; Paesmans, Marianne; Cardoso, Fatima; Desmedt, Christine; Di Leo, Angelo; Chan, Stephen; Friedrichs, Kay; Pinter, Tamas; Van Belle, Simon; Murray, Elizabeth; Bodrogi, István; Walpole, Euan; Lesperance, Bernard; Korec, Stefan; Crown, John; Simmonds, Peter; Perren, Thimothy J.; Leroy, Jean-Yves; Rouas, Ghizlane; Sotiriou, Christos; Piccart-Gebhart, Martine; Larsimont, Denis
Informations sur la publication:Molecular cancer therapeutics, 3, 10, page (1207-1214)
Statut de publication:Publié, 2004-10
Sujet CREF:Cancérologie
Médecine pathologie humaine
MeSH keywords:Adult
Aged
Antigens, Neoplasm
Breast Neoplasms -- drug therapy
Breast Neoplasms -- enzymology
Cell Line, Tumor
DNA Topoisomerases, Type II, Eukaryotic -- biosynthesis
DNA Topoisomerases, Type II, Eukaryotic -- genetics
DNA-Binding Proteins
Doxorubicin -- therapeutic use
Female
Humans
Immunohistochemistry
Middle Aged
Multivariate Analysis
Odds Ratio
Receptor, erbB-2 -- metabolism
Retrospective Studies
Taxoids -- therapeutic use
Treatment Outcome
Tumor Markers, Biological
Note générale:Clinical Trial
Clinical Trial, Phase III
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:1535-7163
info:pii/3/10/1207
info:scp/7444252789
info:pmid/15486187
VX-005278

Documents en relation

DI-fusion